NHS Greater Glasgow and Clyde

Funded awards at NHS Greater Glasgow and Clyde.

Funded awards
16
Published Funding
£7.0M
Average published award
£873K
Active funded awards
3

Amounts are published for 8 of 16 funded awards. Data as of 16 July 2026.

See funded awards Open the Map

The biggest topic here is Cancer — 9 grants (56%). The busiest year was 2014, with 3 grants.

Funded Awards by Year

View data table
YearFunded awards
20071
20081
20111
20121
20143
20153
20181
20201
20211
20231
20241

Grants

Early Vasopressors in Sepsis (EVIS)NHS Greater Glasgow and ClydeNIHR£2.9M2021Active
SWIFT LUNG - Streamlined Workflow for Investigation and Fast Tracking Lung Cancer DiagnosisNHS Greater Glasgow and ClydeNIHR£1.7M2026Active
Anaesthesia Choice for Creation of ArtEriovenous FiStulae (ACCESs study) A randomised controlled trial comparing clinical (one-year functional patency rate) and cost-effectiveness of regional versus local anaesthesia for primary arteriovenous fistula formationNHS Greater Glasgow and ClydeNIHR£1.2M2020Completed
Explanatory comparative study of conventional Total Knee Arthroplasty versus Robotic assisted Bi-UniCompartmental Knee ArthroplastyNHS Greater Glasgow and ClydeNIHR£703K2014Active
A multi-site randomized controlled trial comparing regional and general anaesthesia for effects on neurodevelopmental outcome and apnoea in infantsNHS Greater Glasgow and ClydeNIHR£180K2008Completed
Diagnostic accuracy of the Thessaly Test, standardised clinical history, and other clinical examination tests for meniscal tearsNHS Greater Glasgow and ClydeNIHR£146K2012Completed
Scottish Hepatology Access Research Partnership (SHARP)NHS Greater Glasgow and ClydeNIHR£90K2023Completed
The correlation of hypoxic imaging using PET F-MISO with pathological specimens in patients undergoing neoadjuvant (chemo) radiotherapy for borderline resectable pancreatic cancerNHS Greater Glasgow and ClydePancreatic Cancer UK£75K2018Completed
CRUK/07/002: HER-PCI: Prospective randomised clinical trial testing the role of prophylactic cranial irradiation in patients treated with Trastuzmamb (Herceptin) for metastatic breast cancerNHS Greater Glasgow and ClydeCRUKNot disclosed2007Completed
CRUK/10/031: CARMENA: A randomised phase III trial to evaluate the benefit of nephrectomy in patients with metastatic at diagnosis kidney cancer treated with Antiangiogenics (Sunitinib)NHS Greater Glasgow and ClydeCRUKNot disclosed2011Completed
CRUK/13/020: A randomized phase II study evaluating the role of maintenance therapy with cabozantinib vs placebo in High Grade Uterine Sarcoma (HGUS) after stabilization or response to CT following surgery or in metastatic 1st-line treatment (International Rare Cancers Initiative study - IRCI 006)NHS Greater Glasgow and ClydeCRUKNot disclosed2015Completed
CRUK/14/040 ADSCaN - A Randomised Phase II study of Accelerated, Dose escalated, Sequential Chemo-radiotherapy in Non Small Cell Lung CancerNHS Greater Glasgow and ClydeCRUKNot disclosed2015Completed
CRUKD/15/003 HIPROC A Phase I/Ib study of the oral Hedgehog inhibitor, LY2940680 in combination with weekly paclitaxel in patients with platinum resistant recurrent ovarian cancer or refractory advanced solid tumours.NHS Greater Glasgow and ClydeCRUKNot disclosed2015Completed
CRUKE/12/024: NiCCC - A randomised phase II study of BIBF 1120 compared to chemotherapy in patients with recurrent clear cell carcinoma of the ovary or endometriumNHS Greater Glasgow and ClydeCRUKNot disclosed2014Completed
CRUKE/12/024: NiCCC SC - Nintedanib in Clear Cell Carcinoma - sample collection for translational studiesNHS Greater Glasgow and ClydeCRUKNot disclosed2014Completed
Test, Evidence, Transition Programme Phase 2, Colorectal (Bowel) Cancer: NHS Greater Glasgow and ClydeNHS Greater Glasgow and ClydeCRUKNot disclosed2024Completed